Approval · Notice of Compliance 29025 · 2022
RYALTRIS: Notice of Compliance 29025
Issued September 21, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29025
- Date
- September 21, 2022
- Company
- Glenmark Specialty SaNeuchâtel, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYALTRIS | 02531186 | Marketed |
Medicinal ingredients
- OLOPATADINE HCL 665 MCG per SPR
- MOMETASONE FUROATE MONOHYDRATE 25 MCG per SPR